Physician

Aaiza Aamer, M.D.

According to 2025 Medicare claims, Aaiza Aamer, M.D. (NPI: 1013369552) practices geriatric medicine in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. This provider's primary affiliated billing organization is RWJBH PRIMARY CARE SERVICES (NPI: 1265037501; TIN: 853737205) and primary practice location at 07002-3713. Aamer is affiliated with the RWJBH Accountable Care, LLC (ACO ID: A1247), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Aamer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 159 traditional Medicare patients, billed 407 HCPCS/CPT codes, and received $35,957 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,878 prescription claims across 193 beneficiaries totaling $206,539 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 3 records totaling $69. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $21,681 and ending at $206,539. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	18	34	$4,038
2022	33	80	$7,847
2023	56	109	$8,905
2024	159	407	$35,957

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	44	314	$21,681
2017	120	796	$63,703
2018	72	536	$76,253
2019	68	551	$40,889
2020	22	85	$2,785
2021	15	57	$857
2022	32	187	$7,410
2023	65	410	$31,805
2024	193	1,878	$206,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	36	36	$161
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	23	23	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	29	45	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	29	41	$73
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	41	48	$38

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	26	1,710	$30,472
Jardiance	Empagliflozin	37	1,420	$28,114
Januvia	Sitagliptin Phosphate	35	1,276	$23,150
Belsomra	Suvorexant	18	540	$7,890
Premarin	Estrogens, Conjugated	17	744	$7,853

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$69	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaiza Aamer, M.D.?

Tedicare shows public-source Medicare data for Aaiza Aamer, M.D. (NPI 1013369552), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaiza Aamer, M.D. have ACO affiliation data?

Aaiza Aamer, M.D. is shown with ACO affiliation data for RWJBH Accountable Care, LLC (MSSP, ACO ID A1247), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Aaiza Aamer, M.D.?

Aaiza Aamer, M.D. is linked to RWJBH PRIMARY CARE SERVICES (billing NPI 1265037501) in the available physician profile data.

Does Aaiza Aamer, M.D. have Open Payments data?

Aaiza Aamer, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.